MétaCan
Menu
Back to cohort
Record W3082734312 · doi:10.1172/jci.insight.142362

A simple protein-based surrogate neutralization assay for SARS-CoV-2

2020· article· en· W3082734312 on OpenAlexafffund
Kento T. Abe, Zhijie Li, Reuben Samson, Payman Samavarchi‐Tehrani, Emelissa J. Valcourt, Heidi Wood, Patrick Budylowski, Alan P. Dupuis, Roxie C. Girardin, Bhavisha Rathod, Jenny H. Wang, Miriam Barrios‐Rodiles, Karen Colwill, Allison McGeer, Samira Mubareka, Jennifer L. Gommerman, Yves Durocher, Mario Ostrowski, Kathleen A. McDonough, Michael Drebot, Steven J. Drews, James M. Rini, Anne‐Claude Gingras

Bibliographic record

VenueJCI Insight · 2020
Typearticle
Languageen
FieldMedicine
TopicSARS-CoV-2 and COVID-19 Research
Canadian institutionsUniversity of ManitobaCanadian Blood ServicesSunnybrook Health Science CentreSt. Michael's HospitalUniversity of TorontoNational Research Council CanadaSinai Health SystemSunnybrook HospitalHealth Sciences CentreMount Sinai HospitalLunenfeld-Tanenbaum Research InstitutePublic Health Agency of Canada
FundersNational Institute of Allergy and Infectious DiseasesNational Institutes of HealthKrembil FoundationCanada Foundation for InnovationCanada Research ChairsGovernment of OntarioRoyal Bank of CanadaCanadian Institutes of Health ResearchGenome CanadaOntario GenomicsNew York State Department of Health
KeywordsAntibodyVirologyNeutralizationVirusImmune systemCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Viral loadNeutralizing antibodyImmunologyMedicineCoronavirus disease 2019 (COVID-19)BiologyInfectious disease (medical specialty)

Abstract

fetched live from OpenAlex

Most of the patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mount a humoral immune response to the virus within a few weeks of infection, but the duration of this response and how it correlates with clinical outcomes has not been completely characterized. Of particular importance is the identification of immune correlates of infection that would support public health decision-making on treatment approaches, vaccination strategies, and convalescent plasma therapy. While ELISA-based assays to detect and quantitate antibodies to SARS-CoV-2 in patient samples have been developed, the detection of neutralizing antibodies typically requires more demanding cell-based viral assays. Here, we present a safe and efficient protein-based assay for the detection of serum and plasma antibodies that block the interaction of the SARS-CoV-2 spike protein receptor binding domain (RBD) with its receptor, angiotensin-converting enzyme 2 (ACE2). The assay serves as a surrogate neutralization assay and is performed on the same platform and in parallel with an ELISA for the detection of antibodies against the RBD, enabling a direct comparison. The results obtained with our assay correlate with those of 2 viral-based assays, a plaque reduction neutralization test (PRNT) that uses live SARS-CoV-2 virus and a spike pseudotyped viral vector-based assay.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Methods · Consensus signal: Methods
Teacher disagreement score0.002
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0020.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0020.001
Insufficient payload (model declined to judge)0.0020.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.089
GPT teacher head0.361
Teacher spread0.272 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations238
Published2020
Admission routes2
Has abstractyes

Explore more

Same venueJCI InsightSame topicSARS-CoV-2 and COVID-19 ResearchFrench-language works237,207